Predicting prostate radiotherapy toxicity in a phase III trial using clinical/dosimetric variables in logistic regression and random forest models
Affiliation
University of Rochester Medical Center, Rochester, NYIssue Date
2019
Metadata
Show full item recordCitation
Kang J, Strawderman R, Dearnaley D, Hall E, Burnet N, West CML, et al. Predicting prostate radiotherapy toxicity in a phase III trial using clinical/dosimetric variables in logistic regression and random forest models. Int J Radiat Oncol Biol Phys. 2019;105(1):E285.Journal
International Journal of Radiation Oncology Biology PhysicsDOI
10.1016/j.ijrobp.2019.06.1820Additional Links
https://dx.doi.org/10.1016/j.ijrobp.2019.06.1820Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.ijrobp.2019.06.1820